Back to UBS Group AG UBS Group AG

SGMTSGMT
12 quarters

Position history for UBS Group AGUBS Group AG's holdings in SAGIMET BIOSCIENCES INC A

UBS Group AG holds 339,930 shares of SGMT (SAGIMET BIOSCIENCES INC A), worth $2.6M as of 2026-Q2. The position was increased (+15.7% shares). SGMT represents 0.0% of UBS Group AG's portfolio.

Current Value

$2.6M

Current Shares

339,930

Total Value Change

+$2.6M

Total Shares Change

+336,939

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
339,930
+15.7%
$2.6M0.0%$7.73
30
2026-Q1
Increased
293,934
+45.7%
$1.5M0.0%$5.62
35
2025-Q4
Decreased
201,759
-34.2%
$1.2M0.0%$5.85
0
2025-Q3
Decreased
306,766
-46.4%
$2.1M0.0%$6.92
0
2025-Q2
Increased
572,735
+19.7%
$4.4M0.0%$7.87
32
2025-Q1
Increased
478,430
+43.6%
$1.6M0.0%$3.71
34
2024-Q4
Increased
333,160
+135.8%
$1.5M0.0%$4.72
41
2024-Q3
Increased
141,265
+46.6%
$391,3040.0%$2.82
32
2024-Q2
Increased
96,372
+52.6%
$329,5920.0%$3.42
33
2024-Q1
Increased
63,136
+215.9%
$342,1970.0%$5.42
38
2023-Q4
Increased
19,988
+568.3%
$108,3350.0%$5.42
24
2023-Q3
New
2,991
-
$26,3210.0%$8.80
29

Other major holders of SGMT: BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P., Woodline Partners LP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used